Jupeng Yuan

1.1k total citations
31 papers, 837 citations indexed

About

Jupeng Yuan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jupeng Yuan has authored 31 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jupeng Yuan's work include RNA Research and Splicing (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Jupeng Yuan is often cited by papers focused on RNA Research and Splicing (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Jupeng Yuan collaborates with scholars based in China, United States and Australia. Jupeng Yuan's co-authors include Yaoqin Gong, Ming Yang, Baichun Jiang, Changshun Shao, Yanyan Qian, Nasha Zhang, Huili Hu, Yongxin Zou, Wei Zhao and Yan Wang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jupeng Yuan

31 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jupeng Yuan China 18 633 275 145 139 82 31 837
Zhu Mei China 13 609 1.0× 331 1.2× 94 0.6× 206 1.5× 81 1.0× 22 850
Sajjeev Jagannathan United States 11 525 0.8× 260 0.9× 105 0.7× 119 0.9× 66 0.8× 22 735
Kendra Allton United States 11 909 1.4× 305 1.1× 153 1.1× 254 1.8× 37 0.5× 15 1.1k
Juliane Braun Germany 16 648 1.0× 437 1.6× 196 1.4× 106 0.8× 32 0.4× 22 976
Hyung Seok Kim South Korea 17 701 1.1× 395 1.4× 63 0.4× 145 1.0× 152 1.9× 29 900
Valentina Serafin Italy 14 545 0.9× 294 1.1× 110 0.8× 162 1.2× 56 0.7× 28 783
Ran-Yi Liu China 18 487 0.8× 242 0.9× 130 0.9× 298 2.1× 88 1.1× 26 882
Heiko Stahl Germany 10 433 0.7× 148 0.5× 272 1.9× 133 1.0× 44 0.5× 13 701
Gilles Doumont Belgium 13 531 0.8× 147 0.5× 132 0.9× 349 2.5× 100 1.2× 24 825
Sophie Couvé France 11 495 0.8× 259 0.9× 118 0.8× 219 1.6× 228 2.8× 20 779

Countries citing papers authored by Jupeng Yuan

Since Specialization
Citations

This map shows the geographic impact of Jupeng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jupeng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jupeng Yuan more than expected).

Fields of papers citing papers by Jupeng Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jupeng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jupeng Yuan. The network helps show where Jupeng Yuan may publish in the future.

Co-authorship network of co-authors of Jupeng Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Jupeng Yuan. A scholar is included among the top collaborators of Jupeng Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jupeng Yuan. Jupeng Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Aimin, Hong Lu, Rui Zhao, Jupeng Yuan, & Dawei Chen. (2025). The impact of pre-existing interstitial lung disease on radiation and checkpoint inhibitor pneumonitis in lung cancer patients: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology. 17. 22783360–22783360. 1 indexed citations
2.
Zhang, Zengfu, Tian Chen, Xu Liu, et al.. (2025). Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. Cancer Letters. 625. 217759–217759. 2 indexed citations
3.
Tao, Zhong, Ying Xu, Zengfu Zhang, et al.. (2025). Molecular profiling of skin cells identifies distinct cellular signatures in radiation-induced skin injury across various stages in the murine dataset. Experimental Hematology and Oncology. 14(1). 18–18. 1 indexed citations
4.
Huang, Xinyi, Baoqing Tian, Jupeng Yuan, et al.. (2024). CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling. Therapeutic Advances in Medical Oncology. 16. 12734407–12734407. 1 indexed citations
5.
6.
Liu, Xu, et al.. (2024). Spatial interaction and functional status of CD68+SHP2+ macrophages in tumor microenvironment correlate with overall survival of NSCLC. Frontiers in Immunology. 15. 1396719–1396719. 3 indexed citations
7.
Qian, Xin, Qinghong Ji, Ying Zhang, et al.. (2022). Aberrant ROS Served as an Acquired Vulnerability of Cisplatin‐Resistant Lung Cancer. Oxidative Medicine and Cellular Longevity. 2022(1). 1112987–1112987. 6 indexed citations
8.
Qiu, Xiaoguang, Yidong Chen, Jupeng Yuan, et al.. (2018). Functional BCL-2 rs2279115 Promoter Noncoding Variant Contributes to Glioma Predisposition, Especially in Males. DNA and Cell Biology. 38(1). 85–90. 20 indexed citations
9.
Yuan, Jupeng, Nasha Zhang, Yan Zheng, et al.. (2018). LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A. DNA and Cell Biology. 37(9). 750–757. 23 indexed citations
10.
Chen, Yidong, Nasha Zhang, Xiaoguang Qiu, Jupeng Yuan, & Ming Yang. (2018). LncRNA CDKN2BAS rs2157719 genetic variant contributes to medulloblastoma predisposition. The Journal of Gene Medicine. 20(1). 10 indexed citations
11.
Yuan, Jupeng, Nasha Zhang, Hui Zhu, et al.. (2017). Clinical Implications of the Autophagy Core Gene Variations in Advanced Lung Adenocarcinoma Treated with Gefitinib. Scientific Reports. 7(1). 17814–17814. 24 indexed citations
12.
Ren, Yanli, Jinhua Shang, Jinliang Li, et al.. (2017). The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma. Journal of Biological Chemistry. 292(43). 17939–17949. 47 indexed citations
13.
Yuan, Jupeng, Nasha Zhang, Hui Zhu, et al.. (2017). CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer. Scientific Reports. 7(1). 11802–11802. 8 indexed citations
14.
Qian, Yanyan, Jupeng Yuan, Huili Hu, et al.. (2015). The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment. Cancer Research. 75(23). 5070–5083. 47 indexed citations
15.
Yuan, Jupeng, Baichun Jiang, Aizhen Zhang, et al.. (2015). Accelerated hepatocellular carcinoma development in CUL4B transgenic mice. Oncotarget. 6(17). 15209–15221. 24 indexed citations
16.
Zhao, Wei, Baichun Jiang, Huili Hu, et al.. (2015). Lack of CUL4B leads to increased abundance of GFAP-positive cells that is mediated by PTGDS in mouse brain. Human Molecular Genetics. 24(16). 4686–4697. 18 indexed citations
17.
Yuan, Jupeng, Bo Han, Huili Hu, et al.. (2014). CUL4B activates Wnt/β‐catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists. The Journal of Pathology. 235(5). 784–795. 59 indexed citations
18.
Ji, Qinghong, Huili Hu, Fan Yang, et al.. (2014). CRL4B interacts and coordinates with SIN3A/HDAC complex to repress CDKN1A in driving cell cycle progression. Journal of Cell Science. 127(Pt 21). 4679–91. 30 indexed citations
19.
Jiang, Baichun, Wei Zhao, Jupeng Yuan, et al.. (2012). Lack of Cul4b, an E3 Ubiquitin Ligase Component, Leads to Embryonic Lethality and Abnormal Placental Development. PLoS ONE. 7(5). e37070–e37070. 67 indexed citations
20.
Hu, Huili, Yang Yang, Qinghong Ji, et al.. (2012). CRL4B Catalyzes H2AK119 Monoubiquitination and Coordinates with PRC2 to Promote Tumorigenesis. Cancer Cell. 22(6). 781–795. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhu Mei Breakdown of academic impact, for papers by Sajjeev Jagannathan Breakdown of academic impact, for papers by Kendra Allton Breakdown of academic impact, for papers by Juliane Braun Breakdown of academic impact, for papers by Hyung Seok Kim Breakdown of academic impact, for papers by Valentina Serafin Breakdown of academic impact, for papers by Ran-Yi Liu Breakdown of academic impact, for papers by Heiko Stahl Breakdown of academic impact, for papers by Gilles Doumont Breakdown of academic impact, for papers by Sophie Couvé
Rankless by CCL
2026